Top broker thinks there’s still more upside in the A2 Milk share price

Below we take a look at why Macquarie Wealth Management still believes A2M's share price has room to run.

A2 Milk share price: positivity returns

Not a great time to be short.

The a2 Milk (ASX: A2M) share price finished yesterday’s session 11% higher after the company reported a solid growth outlook for the first-half of the fiscal year and revealed that it expected FY20 margins to be better than previously expected.

Here, the company elaborated that:

'Our progress thus far in the first half FY20 is very encouraging and, given that we are 6 weeks away from the close of this half we have confidence in providing a details first half outlook, which demonstrates progress being made in the early stages of our strategy execution.’

Additionally and speaking to the specifics of the company’s current focus, it was noted that:

'For this phase of our business, we consider the most important metrics to measure our success are a series of brand metrics in core markets - awareness, trial and loyalty conversion; share of category consumption; absolute revenue growth, and healthy underlying gross margins, by product category.’

Investors – who decisively fell out of love with the stock during the middle of this year – look to have grown infatuated again on such comments. Indeed, the A2 Milk share price has built on yesterday’s gains, rising another 2% today as investors scrambled to get back in on the market darling.

Practise trading A2 Milk and other Australian stocks with an IG demo account now

The analyst outlook

Macquarie Wealth Management took yesterday’s positive outlook from A2M to reiterate their outperform rating and bump up their 12-month share price target from A$15.70 to A$16.20 on the milk stock.

At today’s price levels, that would equate to potential upside of around 18%.

Specifically, as a result of yesterday's AGM update as well as commentary on the first-half outlook, Macquarie made some slight adjustments to their expectations regarding A2's earnings outlook.

The investment bank now expects profits (NPAT) of NZ$354.4m in FY20, NZ$429.0m in FY21, and NZ$ 498.9m in FY22.

In addition to this, Macquarie sees potential new products and the company's official 1H FY20 results – expected to be released in February – as the two potentially bullish price catalysts for the stock, at this point.

Maybe more importantly, Macquarie believes that yesterday’s update regarding margins addresses many of the market's core concerns that saw the stock bid lower in recent times. Though brokers such as Citibank remain bearish on this front in the medium-term.

The investment bank also noted that historically, a2 Milk (ASX: A2M) tends to deliver stronger revenue growth in the second half of the fiscal year than it does the first half – typically in the +12-15% range.

On such assumptions, Macquarie notes A2M could be looking at full-year revenues of NZ$1,680m.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.


Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.